Guest editors' note on special issue on real-world experience and randomized clinical trials.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 579, doi. 10.1080/10543406.2019.1643360
- By:
- Publication type:
- Article
Works matching IS 1054-3406 AND VI 29 AND IP 4 AND DT 2019
Results: 14
1
2
Finding the intended use population for a new treatment.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 675, doi. 10.1080/10543406.2019.1636812
- By:
- Publication type:
- Article
3
Commentary on "Applying CHW method to 2-in-1 design: gain or lose".
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 722, doi. 10.1080/10543406.2019.1634088
- By:
- Publication type:
- Article
4
Generalization of the time-to-event continual reassessment method to bivariate outcomes.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 635, doi. 10.1080/10543406.2019.1634087
- By:
- Publication type:
- Article
5
Randomization-based analysis of covariance for inference in the sequential parallel comparison design.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 696, doi. 10.1080/10543406.2019.1633660
- By:
- Publication type:
- Article
6
On the relative efficiency of model-assisted designs: a conditional approach.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 648, doi. 10.1080/10543406.2019.1632881
- By:
- Publication type:
- Article
7
Power calculation in stepped-wedge cluster randomized trial with reduced intervention sustainability effect.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 663, doi. 10.1080/10543406.2019.1633658
- By:
- Publication type:
- Article
8
Robust outcome weighted learning for optimal individualized treatment rules.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 606, doi. 10.1080/10543406.2019.1633657
- By:
- Publication type:
- Article
9
Estimating the subgroup and testing for treatment effect in a post-hoc analysis of a clinical trial with a biomarker.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 685, doi. 10.1080/10543406.2019.1633655
- By:
- Publication type:
- Article
10
Applying CHW method to 2-in-1 design: gain or lose?
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 714, doi. 10.1080/10543406.2019.1633656
- By:
- Publication type:
- Article
11
Bias-adjusted Kaplan–Meier survival curves for marginal treatment effect in observational studies.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 592, doi. 10.1080/10543406.2019.1633659
- By:
- Publication type:
- Article
12
Good statistical practice in utilizing real-world data in a comparative study for premarket evaluation of medical devices.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 580, doi. 10.1080/10543406.2019.1632880
- By:
- Publication type:
- Article
13
Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups.
- Published in:
- Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 625, doi. 10.1080/10543406.2019.1633654
- By:
- Publication type:
- Article
14
Bioequivalence and Statistics in Clinical Pharmacology: by S. Patterson and B. Jones, 2017, Chapman and Hall/CRC: Boca Raton, FL 33487-2742. 434 pp., + xxv, £76.99, Hardback, ISBN 9781584885306.
- Published in:
- 2019
- By:
- Publication type:
- Book Review